登录

需要订阅 JoVE 才能查看此.

An In Vitro Assay for Studying the Cytotoxicity of Pre-Activated CD8+ T Cells against Cancer Cells

-- views • 0:0 min

成績單

Take two CD8+ T cell populations: effector  CD8+ T cells pre-activated through antibody-mediated engagement of T cell and co-stimulatory receptors and suppressed CD8+ T cells inhibited by myeloid-derived suppressor cells.

Add these T cells to basement-membrane-coated wells with cancer cells expressing a nuclear-restricted fluorescent protein.

Pipette a fluorogenic  caspase-3 substrate — a DNA-binding fluorogenic dye conjugated to a caspase-3 recognition site-containing peptide.

Incubate. Effector T cell receptors bind to the class I MHC-peptide complex on the cancer cells, triggering the release of cytotoxic granules containing perforins and granzymes.

Perforins create cancer cell membrane pores, allowing granzyme entry and caspase activation, initiating apoptosis.

Activated caspases additionally cleave the fluorogenic caspase substrate, releasing the dye that binds to DNA and fluoresces.

Under a fluorescence microscope, cancer cells co-cultured with effector T cells exhibit dual nuclear fluorescence, indicating cancer cell apoptosis.

In contrast, cancer cells co-cultured with suppressed T cells display only nuclear protein fluorescence, suggesting non-apoptotic cells.

JoVE Logo

政策

使用条款

隐私

科研

教育

关于 JoVE

版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。